
Heterocyclic Communications p. 251 - 261 (2009)
Update date:2022-09-26
Topics:
Havaldar, Freddy H.
Patil, Abhay R.
A series of novel substituted N-(6-substituted-4H-benzo[e][1,3]oxazin-3-yl) - 2-[4-(4-oxo-2-phenyl-4H-quinazolin-3-yl)-phenoxy]-acetamides (9a-b) and N-(6-substituted-2-thione-4H-benzo[e][1,3]oxazin-3-yl)-2-[4-(4-oxo-2-phenyl-4H- quinazolin-3-yl)-phenoxy]
View MoreBeijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Doi:10.1007/BF01145806
(1989)Doi:10.1016/S0040-4039(02)02024-5
(2002)Doi:10.1002/ejic.200900650
(2009)Doi:10.1021/jo1007338
(2010)Doi:10.1016/0022-328X(88)83050-X
(1988)Doi:10.1016/S0040-4039(00)80716-9
(1988)